lu 135252 has been researched along with Cardiac Remodeling, Ventricular in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boujedaini, H; Henry, JP; Mulder, P; Münter, K; Renet, S; Richard, V; Thuillez, C | 1 |
| Miyauchi, T | 1 |
| Daemen, MJ; Dorenkamp, M; Reinecke, A; Simon, R; Unger, T; Xia, QG | 1 |
| Amann, K; Banas, B; Orth, SR; Ritz, E; Schiele, G | 1 |
| Calderoni, A; Cernacek, P; Nguyen, QT; Picard, P; Rouleau, JL; Sirois, P; Stewart, DJ; White, M | 1 |
| Bouchart, F; Derumeaux, G; Mulder, P; Münter, K; Richard, V; Thuillez, C | 1 |
| Albernaz, A; Kirchengast, M; Moe, GW; Naik, GO; Stewart, DJ | 1 |
| Bauersachs, J; Ertl, G; Fraccarollo, D; Galuppo, P | 1 |
1 review(s) available for lu 135252 and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
[Endothelin and heart failure].
Topics: Animals; Biomarkers; Clinical Trials as Topic; Drug Design; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Heart Failure; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neovascularization, Pathologic; Peptides, Cyclic; Phenylpropionates; Pyrimidines; Transcription Factors; Vasoconstriction; Ventricular Remodeling | 2004 |
7 other study(ies) available for lu 135252 and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Coronary Vessels; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Endothelin Receptor Antagonists; Heart Failure; Hemodynamics; Ligation; Male; Myocardium; Peptidyl-Dipeptidase A; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; Stroke Volume; Survival Rate; Ventricular Function, Left; Ventricular Remodeling; Wakefulness | 2002 |
Effects of endothelin ETA receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure.
Topics: Animals; Blood Pressure; Endothelin A Receptor Antagonists; Heart Failure; Heart Rate; Hypertension; Male; Myocardium; Organ Size; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred SHR; Ventricular Remodeling | 2006 |
Effect of a selective endothelin receptor A blocker on cardiovascular remodeling in uninephrectomized spontaneously hypertensive rats of the stroke-prone strain.
Topics: Animals; Aorta, Thoracic; Arterioles; Blood Pressure; Body Weight; Cardiovascular System; Disease Models, Animal; Endothelin A Receptor Antagonists; Genetic Predisposition to Disease; Hypertrophy; Male; Nephrectomy; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred SHR; Stroke; Tunica Media; Ventricular Remodeling | 2007 |
Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat.
Topics: Animals; Blood Pressure; Endothelin Receptor Antagonists; Intubation, Gastrointestinal; Isomerism; Male; Myocardial Infarction; Phenylpropionates; Pulmonary Artery; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Ventricular Remodeling | 1998 |
Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
Topics: Animals; Blood Pressure; Cardiac Output; Collagen; Coronary Vessels; Dose-Response Relationship, Drug; Echocardiography; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Heart Rate; Hemodynamics; Ligation; Male; Myocardium; Organ Size; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Vasoconstrictor Agents; Ventricular Remodeling; Viper Venoms | 1998 |
Beneficial effects of long-term selective endothelin type A receptor blockade in canine experimental heart failure.
Topics: Administration, Oral; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Dogs; Echocardiography; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Male; Norepinephrine; Phenylpropionates; Pyrimidines; Random Allocation; Receptor, Endothelin A; Vascular Resistance; Ventricular Remodeling | 1998 |
Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling.
Topics: Animals; Blotting, Western; Collagen; Collagen Type I; Collagen Type III; Collagenases; Endothelin Receptor Antagonists; Female; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; Models, Animal; Myocardial Infarction; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling | 2002 |